HOME >> MEDICINE >> NEWS
MR spectroscopy significantly reduces need for breast biopsy

OAK BROOK, Ill.--In a study featured in the June issue of Radiology, researchers found that imaging suspicious breast lesions with magnetic resonance (MR) spectroscopy reduced the need for biopsy by 58 percent. The investigators, from Memorial Sloan-Kettering Cancer Center in New York, discovered that with the addition of MR spectroscopy to their breast MR imaging (MRI) protocol, 23 of 40 suspicious lesions could have been spared biopsy, and none of the resultant cancers would have been missed.

"All cancers in this study were identified with MR spectroscopy. There were no false-negative results," said Lia Bartella, M.D., lead investigator and assistant professor in the Department of Breast Imaging at Memorial Sloan-Kettering. "With the addition of MR spectroscopy to our breast MRI exam, we found that the number of biopsies recommended on the basis of MRI findings decreased significantly. These results should encourage more women to take this potentially life-saving test."

MRI is playing an increasingly important role in the screening of women at high risk for breast cancer. One drawback of the technology, however, has been a considerable number of breast biopsy procedures recommended on the basis of imaging findings, which turn out to be benign. With MR spectroscopy, the radiologist is able to see the chemical make-up of a tumor, so in most cases, he or she can tell without biopsy whether or not the lesion is cancerous.

"Breast tumors have elevated levels of choline compounds, which are a marker of an active tumor," Dr. Bartella said. "By performing a brief MR spectroscopy procedure after an MRI scan, which takes only 10 additional minutes, we can noninvasively see which tumors show elevated choline levels, and therefore which lesions are likely malignant. This eliminates the need for biopsy to find out what the tumor is made of."

In Dr. Bartella's study, 56 patients with 57 breast lesions underwent MRI first, followed by MR spectrosc
'"/>

Contact: Heather Babiar
hbabiar@rsna.org
630-590-7762
Radiological Society of North America
30-May-2006


Page: 1 2

Related medicine news :

1. High-tech spectroscopy may be used to monitor neuropsychiatric symptoms
2. 1.7m to build worlds first SIMS instrument combined with infra-red spectroscopy
3. MR spectroscopy helps identify cancerous breast tumors
4. MR spectroscopy may be superior for determining prostate cancer prognosis
5. Trial stops after stroke and mortality significantly reduced by blood
6. Investigational nonstimulant Guanfacine XR significantly improved child, adolescent ADHD symptoms
7. Full-term, low-birth-weight babies at significantly greater risk for early respiratory symptoms
8. Once-yearly treatment significantly reduces bone fractures in women with postmenopausal osteoporosis
9. New study: Pine bark significantly reduces endometriosis
10. Regular acupressure can significantly reduce agitated behavior in dementia
11. Health care expenditures significantly higher for children with obesity

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: spectroscopy significantly reduces need for breast biopsy

(Date:11/26/2014)... Peoria, Il (PRWEB) November 27, 2014 ... is excited to announce the kick-off of its ... AlignLife encourages people to go to donate to ... will partner with local organizations to distribute the ... December 20th, participating AlignLife locations will be accepting ...
(Date:11/26/2014)... 2014 Recently, Locks-Magnetic.com, a Chinese outstanding ... of magnetic locks on the Internet. It also provides ... December. , As a leading company in the ... worldwide customers to buy high quality locks. It can ... provides locks that are not only useful but also ...
(Date:11/26/2014)... 2014 Pharmaceutical and biotech companies ... levels during manufacturing and research activities, a task ... systems play a key role. Changes in temperature ... while humidity can affect the quality of drugs ... HVAC systems helps to address these problems and ...
(Date:11/26/2014)... Alex Kramer HealthDay Reporter ... rheumatoid arthritis may be more likely to achieve remission if ... The study found that those who were heaviest had ... also lowered the odds of remission. "Medication for rheumatoid ... Dr. Susan Goodman, the study,s lead author and a rheumatologist ...
(Date:11/26/2014)... News) -- Even after they,re cleared to play following ... normal, which suggests they may not be fully recovered, ... a concussion may be symptom-free and cleared by MLB ... residual effects of concussion on the complex motor skills ... principal investigator Dr. Jeffrey Bazarian, an associate professor of ...
Breaking Medicine News(10 mins):Health News:Fresh Products Launched by Famous Company Lock-Magnetic.com 2Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 5Health News:Weight Could Influence Rheumatoid Arthritis Relief 2Health News:Weight Could Influence Rheumatoid Arthritis Relief 3Health News:Harm From Baseball Concussions May Linger, Study Finds 2
(Date:11/26/2014)... Nov. 26, 2014  Cohen, Placitella & Roth, ... investors who purchased Nymox Pharmaceutical Corporation ("Nymox" or ... period from January 31, 2011 through November 2, ... and certain of its officers and directors publically ... of Sections 10(b) and 20(a) of the Securities ...
(Date:11/26/2014)... , Nov. 26, 2014  Avanir Pharmaceuticals, ... the U.S. Food and Drug Administration (FDA) has ... Drug Application (NDA) for AVP-825. AVP-825 is an ... powder delivered intranasally utilizing a novel Breath Powered ... Response letter, and consistent with the preliminary feedback ...
(Date:11/26/2014)... 2014  BioScrip ® , Inc. (NASDAQ: BIOS ) ... Executive Officer, will present at the Bank of America Merrill Lynch ... , Date: , , , Wednesday, December 3, 2014 , ... , , , Location: , , , Boca Raton Resort ... Inc. BioScrip, Inc. is a leading national ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4
Cached News: